首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Urology

Journal Of Urology杂志,由Elsevier Inc.出版,于1917年创刊,Monthly,出版语言English,ISSN:0022-5347,E-ISSN:1527-3792。

投稿咨询
Journal Of Urology
Journal Of Urology
Journal Of Urology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
9.7
CiteScore
10.9
期刊收录
SCI、SCIE

Journal Of Urology(中文译名:《泌尿外科杂志》),ISSN:0022-5347,EISSN:1527-3792,是Elsevier Inc.出版的国际性学术期刊,创刊于1917年,以Monthly形式稳定发行,2026年总发文量约108篇。该刊采用非OA开放访问,学科归属为医学 - 泌尿学与肾脏学。该刊是医学、泌尿学与肾脏学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达9.7,2025年期刊CiteScore为10.9,2025年期刊自引率约5.2%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Journal Of Urology长期聚焦医学、泌尿学与肾脏学及相关产业的技术应用前沿,平均审稿周期很快,2-3周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、泌尿学与肾脏学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACanada、Italy、GERMANY (FED REP GER)、England、France、Japan等为核心发文国家与地区;UNIVERSITY OF CALIFORNIA SYSTEMUNIVERSITY OF TEXAS SYSTEM、HARVARD UNIVERSITY、UNIVERSITY OF TORONTO、CLEVELAND CLINIC FOUNDATION、UNIVERSITY OF WASHINGTON、VANDERBILT UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q1 5 / 134

96.6

学科:UROLOGY & NEPHROLOGY SCIE Q1 5 / 134

96.64

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q1 9 / 133

93.6

学科:UROLOGY & NEPHROLOGY SCIE Q1 9 / 133

93.61


中国学者近期发文

1
Comprehensive Evaluation of Targeted and Perilesional Biopsy in Biopsy-Naïve Patients With Prostate Positive Magnetic Resonance Imaging: PERI-PRO Noninferiority Randomized Controlled Tria

Author:Deng, Ruiyi; Li, Derun; Wu, Jingyun; Tian, Shaojuan; Shen, Qi; Hu, Shuai; Shang, Meixia; Qiu, Jianhui; Shang, Jiaheng; Zhou, Jingcheng; Cai, Lin; Liu, Yi; Gong, Kan

Journal: JOURNAL OF UROLOGY. 2026; Vol. 215, Issue 4, pp. -. DOI: 10.1097/JU.0000000000004863

2
Letter: Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guerin in Bacillus Calmette-Guerin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cance

Author:Feng, Yubin; Zhou, Shuqing; Huang, Shiye; Yu, Zekai; Zhuang, Ziye

Journal: JOURNAL OF UROLOGY. 2026; Vol. 215, Issue 2, pp. -. DOI: 10.1097/JU.0000000000004792

3
Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMI

Author:Ni, Xudong; Sui, Jixinnan; Wang, Beihe; Wang, Hongkai; Freedland, Stephen J.; Ye, Dingwei; Zhu, Yao

Journal: JOURNAL OF UROLOGY. 2025; Vol. 214, Issue 1, pp. 10-17. DOI: 10.1097/JU.0000000000004545

4
Letter: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivor

Author:Wang, Weizhuo; Gao, Chuchu; Fu, Kai

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 6, pp. 790-791. DOI: 10.1097/JU.0000000000004440

5
A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial Carcinom

Author:Huang, Jiwei; Cai, Xingyun; Ng, Cheoklong; Luo, Yuansheng; Chen, Qiong; Wang, Zaoyu; Qiao, Keying; Kong, Wen; Zhang, Jin; Chen, Yonghui; Zhang, Wei; Zhang, Jiyang; Zhang, Dadong; Wu, Guangyu; Chen, Haige; Xue, Wei

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 6, pp. 739-752. DOI: 10.1097/JU.0000000000004475

6
Letter: Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinenc

Author:Fang, Yuekun; Chen, Shengyi; Huang, Chenxiao; Cheng, Bin

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 6, pp. 792-792. DOI: 10.1097/JU.0000000000004486

7
Letter: Adults With Spina Bifida Fare Worse Than Young Adults: A Systemic Vulnerability in Urinary Tract Infection-Related Hospital Care (vol 213, pg 378, 2025

Author:Rao, Wei; Zhang, Liangping

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 6, pp. 818-818. DOI: 10.1097/JU.0000000000004514

8
Letter: A Tailored Electronic Survivorship Care Plan for Prostate Cancer Survivors: A Multicenter Randomized Controlled Tria

Author:Zhang, Fei; Li, Sheng

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 5, pp. 658-659. DOI: 10.1097/JU.0000000000004414

9
Letter: Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortalit

Author:Xu, Junshu; Jiang, Minjun; Lu, Lingxiang

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 5, pp. -. DOI: 10.1097/JU.0000000000004394

10
Letter: Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Condui

Author:Jing, Saisai; Song, Jiazhao

Journal: JOURNAL OF UROLOGY. 2025; Vol. 213, Issue 5, pp. 659-659. DOI: 10.1097/JU.0000000000004407


在线咨询

Journal Of Urology

国际简称:J UROLOGY参考译名:泌尿外科杂志

年发文量:108 CiteScore:10.9 是否预警:否 Gold OA文章占比:14.35% 研究类文章占比:96.30%

杂志社联系方式:ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Journal Of Urology